Intracystic injection of pingyangmycin (PYM) might be a more favorable option for treatment of oral and plunging ranulas
Yang, X.-j.; Zheng, J.-w.; Zhou, Q.; Zhang, S.-y.; Yang, C.
Shanghai Kou Qiang Yi Xue 19(4): 447-448
2010
ISSN/ISBN: 1006-7248 PMID: 20871968 Document Number: 643026
Ranulas are mucoceles that develop as a result of mucous extravasation from the sublingual gland and typically present in the floor of mouth. The treatment of ranulas are various, mainly including surgical and nonsurgical methods. The preferred treatment of oral and plunging ranulas is still uncertain. According to the complications associated with surgical therapy, nonsurgical sclerotherapy has been advocated by clinicians for its advantages of less injury, no scar, less suffering, etc. Recently, it was reported that OK-432 was a relatively effective sclerosing agent for both lymphatic malformations and ranulas, although it has a high rate of recurrence after treating ranulas. Pingyangmycin is another reported conventional sclerosing agent for lymphatic malformations. Herein, we hypothesize that intracystic injection of pingyangmycin may be an optimal method for the treatment of ranulas.